Detection of rare cases of HTLV-I and -II infections and high numbers of HTLV-seroindeterminate results in Bavarian blood donors

Infusionstherapie und Transfusionsmedizin

Volumn 26, Issue 6, 1999, Pages 328-334

  Fleischer, C ^a   Kucherer C ^a   Michel, P ^b   Weise, W ^b   Stahl Hennig, C ^c   Bodemer, W ^c   Hunsmann, G ^c   Pauli, G ^a  

^a ROBERT KOCH INSTITUTE   (Germany)

^b Landesgeschäftstelle Bereich Katastrophenschutz   (Germany)

^c GERMAN PRIMATE CENTER   (Germany)

Author keywords

Blood donors; Human T cell lymphotropic virus types I and II; Polymerase chain reaction

Indexed keywords

ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 2; NONHUMAN; SEROPREVALENCE; VIRUS INFECTION;

HTLV; HTLV I; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN T CELL LYMPHOTROPIC VIRUS TYPE I; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 2;

EID: 0345325552     PISSN: 10198466     EISSN: None     Source Type: Journal    
DOI: 10.1159/000053514     Document Type: Article

References (57)

1. Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC: Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 1980;77:7415-7419.
2. Kalyanaraman VS, Sarngadharan MG, Robert-Guroff M, Miyoshi I, Blayncy D, Golde D, Gallo RC: A new subtype of human T-cell leukemia virus (HTLV-2) associated with a T-cell variant of hairy cell leukemia. Science 1982;218:571-573.
3. Miyoshi I, Kubonishi L, Yoshimoto S, Akagi T, Otsuki Y, Shiraishi Y, Nagata K, Hinuma Y: Type C virus particles in a cord T-cell line derived by cocultivating normal human cord leukocytes and human leukemic T-cells. Nature 1981;294:770-771.
4. Gessain A, Barin F, Vernant JC, Gout O, Maurs L, Calendar A, de Thé G: Antibodies to human T-lymphotropic virus type-1 in patients with tropical spastic paraparesis. Lancet 1985;ii:407-109.
5. Osame M, Usuku K, Izumo S, Ijichi N, Amitani H, Igata A, Matsumoto M, Tara M: HTLV-1 associated myelopathy, a new clinical entity. Lancet 1986;i: 1031-1032.
6. Nakao K, Ohba N, Matsumoto M: Noninfectious anterior uveitis in patients infected with HTLV-1. Jpn J Ophthalmol 1989;33:472-481.
7. Iwakura Y, Tosu M, Yoshida E, Takiguchi M, Sato K, Kitajima I, Nishioka K, Yamamoto K, Takeda T, Hanaka M, Yamamoto K, Sekiguchi T: Induction of inflammatory arthropathy resembling rheumatoid arthritis in mice transgenic for HTLV-1. Science 1991;253:1026-1028.
8. Hjelle B, Appenzeller O, Mills R, Alexander S, Torrez-Martinez N, Jahnke R, Ross G: Chronic neurodegenerative disease associated with HTLV-2 infection. Lancet 1992;339:645.
9. Murphy EL: HTLV-2 related disease. Lancet 1993; 341:888.
10. Donegan E, Lee H, Operskalski EA, Shaw GM, Kleinman SH, Busch MP, Stevens CE, Schiff ER, Nowicki MJ, Hollingsworth CG, Mosley JW, and The Transfusion Safety Study Group: Transfusion transmission of retroviruses: human T-lymphotropic virus types 1 and 2 compared with human immunodeficiency virus type 1. Transfusion 1994;34: 478-483.
11. Williams AE, Fang CT, Sandler SG: HTLV-1/-2 and blood transfusion in the United States; in Blattner WA (ed): Human Retrovirology: HTLV. New York, Raven Press, 1990, pp 349-362.
12. Okochi K, Sato H., Hinuma Y: A retrospective study on transmission of adult T-cell leukemia virus by blood transfusion: Seroconversion in recipients. Vox Sang 1984;46:245-253.
13. Lee HH, Swanson P, Rosenblatt JD, Chen ISY, Sherwood WC, Smith DE, Tegtmeier GE, Fernando LP, Fang CT, Osame M, Kleinmann SH: Relative prevalence and risk factors of HTLV-1 and HTLV-2 infection in US blood donors. Lancet 1991;337:1435-1438.
14. HTLV European Research Network (HERN), Taylor GP, Weber JN: Sero-epidemiology of the human T-cell leukaemia/lymphoma viruses in Europe. J Acquir Immune Defic Syndr Hum Retrovirol 1996,13:68-77.
15. Pillonel J, Lemaire JM, Courouce AM: Epidémiologie de l'HTLV chez les donneurs de sang. Réseau National de Santé Publique et Groupe de Travail Rétrovirus. Transfus Clin Biol 1994;1:51-53.
16. Zaaijer HL, Dudok de Wit C, Cuypers HT, Winkel IN, Lelie PN: De prevalentie van humaan T-lymfotroop virus type 1 onder Nederlandse. Ned Tijdschr Geneeskd 1993;137:2541-2543.
17. Detmar M, Pauli G, Anagnostopoulos I, Wunderlich U, Herbst H, Garbe C, Stein H, Orfanos CE: A case of classical mycosis fungoides associated with human T-cell lymphotropic virus type 1. Br J Dermatol 1991;124:198-202.
18. Rolfs A, Junghan U, Pauli G, Koenecke C, Grützedieck V: Neurologisches Krankheitsbild und Diagnostik einer HTLV-1 Infektion mit Paraparese, Myositis und Sjögren-Syndrom. 2. Deutscher AIDS-Kongress, Berlin, 23/24.01.1989:Abstract no 312.
19. Hunsmann G, Schneider J, Schmitt J, Yamamoto N: Detection of serum antibodies to adult T-cell leukemia virus in non-human primates and in people from Africa. Int J Cancer 1983;32:329-332.
20. Hunsmann G, Schneider J, Bayer H, Berthold H, Schimpf K, Kabisch H, Ritter K, Bienzle H, Schmitz H, Kern P, Dietrich M: Antibodies to adult T-cell leukemia virus (ATLV/HTLV-I) in AIDS patients and people at risk of AIDS in Germany. Med Microbiol Immunol 1985;173:241-250.
21. Pauli G, Ehm I, Gelderblom HR, Koch MA: HTLV-1-Infektionen in der Bundesrepublik Deutschland. Bundesgesundheitsblatt 1990;33:205-209.
22. Schätzl H, Schwarzfischer G, Rose D, Gathof B, Weise W, Deinhard F, Von der Helm K: Prevalence of human T-cell lymphotropic virus infections in Germany. J Med Virol 1994;43:159-160.
23. Centers for Disease Control and Prevention and the U.S.P.H.S. Working Group: Guidelines for counseling persons infected with human T-lymphotropic virus type 1 (HTLV-1) and type 2. Ann Intern Med 1993;118:448-454.
24. Lipka JJ, Miyoshi I, Hadlock KG, Reyes GR, Chow TP, Blattner WA, Shaw GM, Hanson CV, Gallo D, Chan L, Foung SKH: Segregation of human T-cell lymphotropic virus type 1 and 2 infections by antibody reactivity to unique viral epilopes. J Infect Dis 1992;165:26S-272.
25. Lal RB, Brodine S, Kazura J, Mbidde-Katonga E, Yanagihara R, Roberts C: Sensitivity and specificity of a recombinant transmembrane glycoprotein (rgp21)-spiked Western immunoblot for serological confirmation of human T-cell lymphotropic virus type 1 and type 2 infections. J Clin Microbiol 1992;30:296-299.
26. Hadlock KG, Goh CJ, Bradshaw PA, Perkins S, Lo J, Kaplan JE, Khabbaz R, Foung SKH: Delineation of an immunodominant and human T-cell lymphotropic virus (HTLV)-specific epitope within the HTLV-1 transmembrane glycoprotein. Blood 1995; 86:1392-1399.
27. Schneider J, Yamamoto N, Hinuma Y, Hunsmann G: Sera from adult T-cell leukemia patients react with envelope and core polypeptides of adult T-cell leukemia. Virology 1984;132:1-11.
28. Bauer HM, Ting Yi, Greer CE, Chambers JC, Tashiro CJ, Chimera J, Reingold A, Manos MM: Genital human papillomavirus infection in female university students as determined by a PCR-based method. JAMA 1991;265:472-477.
29. Longo MC, Berninger MS, Hartley JL: Use of uracil DNA glycosylase to control carry-over contamination in polymerase chain reactions. Gene 1990;93:125-128.
30. Kwok S, Kellogg D, Ehrlich G, Poiesz B, Bhagavati S, Sninsky JJ: Characterization of a sequence of human T-cell leukemia virus type 1 from a patient with chronic progressive myelopathy. J Infect Dis 1988;158:1193-1197.
31. Maloney E, Biggar R, Neel J, Taylor M, Hahn B, Shaw G, Blattner W: Endemic human T-cell lymphotropic virus type 2 infection among isolated Brazilian Amerindians. J Infect Dis 1992;166:100-107.
32. Gallo D, Penning LM, Hanson CV: Detection and differentiation of antibodies to human T-cell lymphotropic virus types I and II by immunofluorescence method. J Clin Microbiol 1991;29:2345-2347.
33. Arbeitskreis Blut, Untergruppe «Bewertung Blutassoziierter Krankheitserreger»: Human T-cell lymphotropic viruses type 1 and 2 (HTLV-I/-II). Infusionsther Transfusionsmed 1999;26:321-326.
34. Veelken H, Köhler G, Schneider J, Dierbach H, Mertelsmann R, Schaefer HE, Lübbert M: HTLV-I-associated adult T cell leukemia/lymphoma in two patients from Bucharest, Romania. Leukemia 1996;10:1366-1369.
35. Reinhardt P, Maschmeyer G, Carstanjen D, Schulze G, Karawajew LC, Ellerbrok H, Herrmann F, Schlegelberger B, Pauli G, Ludwig WD: First non-imported HTLV-1 positive adult T-cell leukemia (ATL) in Germany. Br J Haematol 1996; 93(suppl 2):364.
36. Ellerbrok H, Fleischer C, Salemi M, Reinhardt P, Ludwig WD, Vandamme AM, Pauli G: Sequence analysis of the first HTLV-I infection in Germany without relations to endemic areas. AIDS Res Hum Retroviruses 1998;14:1199-1203.
37. Borck C: Prävalenz und serologische Charakterisierung von HTLV-1/-2- und HIV-1/-2-Infektionen in Serenpanels aus Brasilien im Vergleich zu Risikogruppen in der Bundesrepublik. Inaugural-dissertation, Freie Universität Berlin, 1996.
38. Lal RB, Rudolph DL, Coligan JE, Brodine SK, Roberts CR: Failure to detect evidence of human T-lymphotropic virus (HTLV) type 1 and type 2 in blood donors with isolated gag antibodies to HTLV-1/-2. Blood 1992;80:544-550.
39. Khabbaz RF, Heneine W, Grindon A, Hartley TM, Shulman G, Kaplan J: Indeterminate HTLV serologic results in US blood donors: Are they due to HTLV-1 or HTLV-2? J Acquir Immune Defic Syndr 1992;5:400-404.
40. Lipka JJ, Young KK, Kwok SY, Reyes GR, Sninsky JJ, Foung SKH: Significance of human T-lymphotropic virus type 1 indeterminant serological findings among healthy individuals. Vox Sang 1991; 61:171-176.
41. Re MC, Furlini G, Ramazotti E, Vignoli M, Zauli G, Lolli S, Monari P, Belletti D, Nanetti A, LaPlaca M: Absence of HTLV-1/-2 infection in blood donors with positive and inconclusive HTLV-I/II serology. Microbiologica 1992;15:329-336.
42. Defer C, Coste J, Descamps F, Voisin S, Lemaire JM, Maniez M, Courouce AM: Contribution of polymerase chain reaction and radioimmunoprecipitation assay in the confirmation of human T-lymphotropic virus infection in French blood donors. Retrovirus study group of the French society of blood transfusion. Transfusion 1995;35:596-600.
43. Roberts BD, Foung SK, Lipka JJ, Kaplan JE, Hadlock KG, Reyes GR, Chan L, Heneine W, Khabbaz RF: Evaluation of an immunoblot assay for seroogical confirmation and differentiation of human T-cell lymphotropic virus types 1 and 2. J Clin Microbiol 1993;31:260-264.
44. Zaaijer HL, Cuypers HTM, Dudok de Wit C, Lelie PN: Results of 1-year screening of donors in The Netherlands for human T-lymphotropic virus (HTLV) type 1: Significance of Western blot patterns for confirmation of HTLV infection. Transfusion 1994;34:877-880.
45. Manns A, Murphy EL, Wilks R, Haynes G, Figueroa JP, Hanchard B, Barnett M, Drummond J, Waters D, Cerney M, Seals JR, Alexander SS, Lee H, Blattner WA: Detection of early human T-cell lymphotropic virus type 1 antibody patterns during scroconversion among transfusion recipients. Blood 1991;77:896-905.
46. Schüpbach J, Baumgartner A, Tomasik Z: HTLV-1 in Switzerland: Low prevalence of specific antibodies in HIV risk groups, high prevalence of cross-reactive antibodies in normal blood donors. Int J Cancer 1988;42:957-862.
47. Hall WW: Human T-cell lymphotropic virus type 1 and cutaneous T-cell leukemia/lymphoma. J Exp Med 1994;180:1581-1585.
48. Goubau P, Van Brussel M, Vandamme AM, Liu H-F, Desmyter J: A primate T-lymphotropic virus, PTLV-L, different from human T-lymphotropic viruses types 1 and 2, in a wild-caught baboon (Papio hamadryas). Proc Natl Acad Sci USA 1994;91: 2848-2852.
49. Liu H, Vandamme AM, Van Brussel M, Desmyter J, Goubau P: New retroviruses in human and simian T-lymphotropic viruses. Lancet 1994;344:265-266.
50. Girl A, Markham P, Digilo L, Hurteau G, Gallo RC, Franchini G: Isolation of a novel simian T-cell lymphotropic virus from Pan paniscus that is distantly related to the human T-cell leukemia/lymphotropic virus types 1 and 2. J Virol 1994;68:8392-8395.
51. Vandamme AM, Van Laethem K, Liu HF, Van Brussel M, Delaporte E, Castro Costa CM, Fleischer C, Taylor G, Bertazzoni U, Desmyter J, Goubau P: Use of a generic PCR assay detecting human T-lymphotropic virus (HTLV) types I, II and divergent simian strains in the evaluation of individuals with indeterminate HTLV serologies. J Med Virol 1997;52:1-7.
52. Giesecke J: HTLV screening of Swedish blood donors. Lancet 1995;345:978.
53. Christiansen CB, Wantzin P, Dickmeiss E: Prevalence of antibodies to HTLV-1/-2 in high-risk patients and blood donors in Denmark. Vox Sang 1995;68:63-64.
54. Kay LA: HTLV-I screening in Britain - blood supply in Britain should be made safer. BMJ 1996;312: 706.
55. Harrison P, Ala FA, Milligan DW, Skidmore S: HTLV-I screening in Britain - failure to screen may be a false economy. BMJ 1996;312:706-707.
56. Hitzler W, Kiefhaber K, Runkel S, Jochum C: Prävalenz des humanen T-Zelleukämie-Virus I/II (HTLV-I/II) bei Dauerblutspendern aus urbanen und ländlichen Gebieten. Infusionsther Transfusionsmed 1996;23:211-215.
57. Duwe S, Fleischer C, Knödler B, Kühnl P, Pauli G, Ellerbrok H: The HTLV type I sequence from an asymptomatic German blood donor is related to sequences from South America. AIDS Res Hum Retroviruses 1998;14:1645-1647.